Codexis (NASDAQ:CDXS) and OriginClear (OTCMKTS:OCLN) are both small-cap industrial products companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, valuation, earnings, analyst recommendations, institutional ownership and profitability.
This is a breakdown of current ratings and recommmendations for Codexis and OriginClear, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Codexis presently has a consensus target price of $17.75, indicating a potential downside of 16.31%. Given Codexis’ higher probable upside, equities analysts plainly believe Codexis is more favorable than OriginClear.
Institutional and Insider Ownership
80.3% of Codexis shares are owned by institutional investors. 11.4% of Codexis shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Valuation and Earnings
This table compares Codexis and OriginClear’s gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Codexis||$50.02 million||22.91||-$22.99 million||($0.50)||-42.42|
|OriginClear||$3.35 million||0.09||-$5.23 million||N/A||N/A|
OriginClear has lower revenue, but higher earnings than Codexis.
This table compares Codexis and OriginClear’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Volatility and Risk
Codexis has a beta of -1.45, indicating that its share price is 245% less volatile than the S&P 500. Comparatively, OriginClear has a beta of -2.32, indicating that its share price is 332% less volatile than the S&P 500.
Codexis beats OriginClear on 9 of the 11 factors compared between the two stocks.
Codexis Company Profile
Codexis, Inc. discovers, develops, and sells protein catalysts. It also offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides protein catalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering protein catalysts that perform chemical transformations. The company's platform is used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. Its platform also enhances the pharmaceuticals companies manufacturing productivity and efficiency or outsourcing the manufacture of the intermediates and active pharmaceutical ingredients. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.
OriginClear Company Profile
OriginClear, Inc. provides water treatment solutions. The company licenses its Electro Water Separation technology worldwide to treat heavily polluted waters, as well as to remove harmful micro-contaminants from drinking water using minimal energy, chemicals, and materials. It also designs and manufactures a line of water treatment systems for municipal, industrial, and pure water applications. In addition, the company offers a range of services, including maintenance contracts, retrofits, and replacement assistance; and rents equipment through contracts of varying duration, as well as provides prefabricated wastewater treatment products. It operates in the United States, Canada, Japan, Argentina, and the Middle East. The company was formerly known as OriginOil, Inc. and changed its name to OriginClear, Inc. in April 2015. OriginClear, Inc. was founded in 2007 and is headquartered in Los Angeles, California.
Receive News & Ratings for Codexis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Codexis and related companies with MarketBeat.com's FREE daily email newsletter.